Epstein Secrets

n this assay. --Test developed and characteristics determined by OUP --Laboratories. See Compliance Statement 4: aruplab.com/CS --www.aruplab,com, Julio Delgado, MD - Lab. Director QUINTANA Affdik (30) SEE BELOW B. quintana Ab, IgM < 1:16 --INTERPRETIVE INFORMATION: Bartonella quintana Ab, Ism -- Less t

KOHAnIth Company ORSHER, STUART PSTEIN, 3EFFREY Specimen ID: 104364919 DOB: 01/20/1953 Age: 64 V Sex: H Date of Rdport:e9/08/201711:39 - STUART ORSHER, A /FL: Bed: it: Date Collected: 08/30/2017 11:Sa Date Received: 08/30/2017 23:12 9 EAST 79TH ST, I atient ID: NEW YORK, NY 10021 Aeet *: "

n this assay. --Test developed and characteristics determined by OUP --Laboratories. See Compliance Statement 4: aruplab.com/CS --www.aruplab,com, Julio Delgado, MD - Lab. Director QUINTANA Affdik (30) SEE BELOW B. quintana Ab, IgM < 1:16 --INTERPRETIVE INFORMATION: Bartonella quintana Ab, Ism -- Less t

BioReference LABORATORI ES en OPKO Health Cur.peny ER, STUART C3070 - STUART ORSHER, K.D. 9 EAST 79TH ST, NEW YORK, NY 10021 Acct 4: C3070 P: MO IA EPSTEIN, JEFFREY 00B: 01/20/1553 Age: 64 V Sex: M U/FL: Bed; Re: Patient

t-infection. --Test developed and characteristics determined by ARUP --Laboratories. See Compliance Statement A: aruplab.com/CS --www.aruplab.com, Julio Delgado, MD - Lab. Director B. quintana Ab, Ig6 <1:64 --INTERPRETIVE INFORMATION: ilartonella quintana Antibody, IgG -- Less than 1:64 Negative: No si

Director Printed 09/22/2017 09:57 EFTA00299766 13ioReference LASORATOR/ES an OPKO Health Company FINAL REPORT ORSHER, STUART C3070 - STUART ORSHER, M.O. 9 EAST 79TH 57, NEW YORK, NY 10021 Acct a: (C3070) P. EPSTEIN, JEFFREY DOB: 01/20/1953 Age: 64 y Sex: H U/FL: Bed: Rm: Patient ID: A